{"product_id":"hims-bcg-matrix","title":"Hims \u0026 Hers Health Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVisual. Strategic. Downloadable.\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eCurious where Hims \u0026amp; Hers Health’s products land — Stars, Cash Cows, Dogs or Question Marks? This preview teases the picture; buy the full BCG Matrix to get quadrant-by-quadrant placements, data-backed recommendations, and a ready-to-use Word report plus an Excel summary. Skip the guesswork, act with clarity, and allocate capital where it actually moves the needle.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eED Rx subscriptions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eED treatments are Hims’ category leader with strong brand recall and heavy repeat use; Hims \u0026amp; Hers reported roughly $518M revenue in 2023 with ED a core driver. The U.S. ED prescription market exceeds $1.5B annually and continues growing as stigma falls and online access rises. CAC is high but subscription economics deliver payback in about 6–9 months, supporting continued investment to defend share and expand SKUs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHair loss Rx (finasteride + minoxidil)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eHair loss Rx (finasteride + minoxidil) is Hims \u0026amp; Hers Health’s flagship growth engine with a dominant DTC market share and a 2024 revenue run-rate near $500M, reflecting durable demand. The proven funnel yields manageably low churn and a solid LTV\/CAC profile, supporting mid-teens category growth as younger demos enter. Continued promo and retail placement sustain visibility and conversion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOwned telehealth + pharmacy fulfillment stack\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOwned end-to-end virtual care plus in-house pharmacy is a durable moat: it shortens prescription turnaround, improves patient experience and captures fulfillment margin, supporting Hims \u0026amp; Hers’ unit economics. The global telehealth market reached about $62.5 billion in 2024, and as adoption expands, the integrated platform scales with demand. Ongoing capex to modernize fulfillment and telehealth tech is justified to protect margin and growth.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand-led DTC performance marketing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eHims \u0026amp; Hers, a top-of-mind DTC health brand, sits in the Stars quadrant, compounding returns as category demand grows; the company reported FY2023 revenue of 616.7 million. Creative testing, influencer partnerships and social channels keep CAC efficient, while scale delivers buying power and richer customer data—keep feeding the engine to sustain growth.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePosition: Star\u003c\/li\u003e\n\u003cli\u003eFY2023 revenue: 616.7M\u003c\/li\u003e\n\u003cli\u003eChannels: creative, influencer, social\u003c\/li\u003e\n\u003cli\u003eAdvantages: scale buying power, data\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCross-sell within sexual health and hair\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eCross-selling sexual health and hair leverages Hims \u0026amp; Hers large installed base to expand into adjacent SKUs, driving higher ARPU through bundles and upgrades while minimizing acquisition spend.\u003c\/p\u003e\n\u003cp\u003ePersonalization and timed offers support growth by improving conversion and retention, maintaining high share within a growing consumer health wallet.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eInstalled-base expansion\u003c\/li\u003e\n\u003cli\u003eBundles raise ARPU\u003c\/li\u003e\n\u003cli\u003eTimed personalization boosts LTV\u003c\/li\u003e\n\u003cli\u003eHigh share in expanding wallet\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital health leader — 616.7M revenue, ~500M hair run-rate, huge ED \u0026amp; telehealth markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHims \u0026amp; Hers is a Star: FY2023 revenue 616.7M, 2024 hair run-rate ~500M, ED market \u0026gt;1.5B and telehealth ~$62.5B (2024). Strong LTV\/CAC (payback 6–9 months), high share in DTC hair and ED, growth via cross-sell, personalization and owned pharmacy.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2023\/24\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue FY2023\u003c\/td\u003e\n\u003ctd\u003e616.7M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHair run-rate 2024\u003c\/td\u003e\n\u003ctd\u003e~500M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eED US market\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;1.5B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eBCG Matrix of Hims \u0026amp; Hers: identifies Stars, Cash Cows, Question Marks, Dogs with investment, hold or divest guidance and trend context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page BCG matrix highlighting Hims \u0026amp; Hers units to pinpoint growth vs pain-point divestment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOTC hair kits (topical minoxidil, shampoos)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOTC hair kits (topical minoxidil, shampoos) are mature, well-known Hims \u0026amp; Hers SKUs with steady repeat purchases and predictable margins; the global hair-loss treatment market was estimated at about $4.1B in 2023, underpinning stable demand. Low innovation cycles mean minimal promo beyond retention, conserving gross margin. These products generate reliable cash flow to fund newer growth bets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeneric ED refills at scale\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGeneric ED refills are price-stable and margin-friendly at scale; generics account for roughly 90% of U.S. prescriptions (FDA), driving predictable unit economics.\u003c\/p\u003e\n\u003cp\u003eThe category is mature versus earlier hypergrowth, with steady demand and lower CAC relative to new product launches.\u003c\/p\u003e\n\u003cp\u003eAuto-ship lowers service costs and smooths cash flow by increasing retention; milk volume economics while maintaining care and adherence levels.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAsynchronous consults for simple conditions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAsynchronous consults for simple conditions streamline intake and can reduce clinician time roughly 50–70% versus live visits, enabling higher clinician capacity. The telehealth market has matured with outpatient tele-visit penetration stabilizing near 15% post-pandemic, so efficiency — not growth — is the lever. High throughput, low friction workflows drive strong unit economics; continue optimizing intake, routing, templates, and tooling to squeeze margin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrivate-label derm basics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePrivate-label derm basics deliver steady, low-single-digit unit growth rather than breakout expansion, acting as a reliable cash cow for Hims \u0026amp; Hers in 2024.\u003c\/p\u003e\n\u003cp\u003eScaled house-brand SKUs drive gross margins in the 55–65% range, require limited ongoing marketing after retail placement, and help cover fixed overhead.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSteady SKU velocity\u003c\/li\u003e\n\u003cli\u003e55–65% gross margins\u003c\/li\u003e\n\u003cli\u003eLow sustained marketing\u003c\/li\u003e\n\u003cli\u003eStable overhead support\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMembership\/auto-ship infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eHims \u0026amp; Hers membership\/auto-ship infrastructure uses automated billing, prescription reminders, and logistics to keep churn low and cashflow predictable, monetizing an established customer base efficiently rather than driving fast top-line growth.\u003c\/p\u003e\n\u003cp\u003eSmall UX, pricing, and fulfillment tweaks typically yield outsized margin gains, supporting a maintain-and-harvest strategy for this cash-cow segment.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eBilling reliability: reduces involuntary churn\u003c\/li\u003e\n\u003cli\u003eReminders + logistics: steady reorder rates\u003c\/li\u003e\n\u003cli\u003eHigh-margin: incremental tweaks amplify profit\u003c\/li\u003e\n\u003cli\u003eStrategy: maintain core, harvest cash\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOTC hair kits: $4.1B market, 55–65% margins, 50–70% clinician time cut\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOTC hair kits and private-label derm basics are mature SKUs with steady repeat purchases; global hair-loss market ~$4.1B in 2023 supports stable demand. Generics (~90% of U.S. scripts) and auto-ship lift unit economics; asynchronous consults cut clinician time ~50–70%, boosting throughput. Gross margins ~55–65% make these reliable cash cows to fund growth bets.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHair market 2023\u003c\/td\u003e\n\u003ctd\u003e$4.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGenerics share (US)\u003c\/td\u003e\n\u003ctd\u003e~90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinician time cut\u003c\/td\u003e\n\u003ctd\u003e50–70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e55–65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You’re Viewing Is Included\u003c\/span\u003e\u003cbr\u003eHims \u0026amp; Hers Health BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the final Hims \u0026amp; Hers Health BCG Matrix you'll receive after purchase. No watermarks, no demo copy—just the fully formatted, analysis-ready report. It's crafted for strategic clarity and immediate use in planning or presentations. Buy once and download the exact same editable document, ready to share with your team.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56164028711289,"sku":"hims-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/hims-bcg-matrix.png?v=1762724602","url":"https:\/\/portersfiveforce.com\/products\/hims-bcg-matrix","provider":"Porter's Five Forces","version":"1.0","type":"link"}